NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Chou R, Deyo R, Friedly J, et al. Noninvasive Treatments for Low Back Pain [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Feb. (Comparative Effectiveness Reviews, No. 169.)
Table F1Quality assessment of systematic reviews of acetaminophen
Study, Year | (1) ‘A priori’ design provided? | (2) Duplicate study selection and data extraction?
| (3) Comprehensive literature search performed? | (4) Status of publication used as an inclusion criteria? | (5) List of studies (included and excluded) provided? | (6) Characteristics of the included studies provided? | (7) Scientific quality of included studies assessed and documented? | (8) Scientific quality of the included studies used appropriately in formulating conclusions? | (9) Methods used to synthesize the findings of studies appropriate? | (10) Likelihood of publication bias assessed? | (11) Conflict of interest stated?
| Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Roelofs, 2008 | Yes |
| Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes |
| Good |
Please see Appendix C. Included Studies for full study references.
Table F2Quality assessment of randomized controlled trials of acetaminophen
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Williams, 2014 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F3Quality assessment of systematic reviews of NSAIDs
Study, Year | (1) ‘A priori’ design provided? | (2) Duplicate study selection and data extraction?
| (3) Comprehensive literature search performed? | (4) Status of publication used as an inclusion criteria? | (5) List of studies (included and excluded) provided? | (6) Characteristics of the included studies provided? | (7) Scientific quality of included studies assessed and documented? | (8) Scientific quality of the included studies used appropriately in formulating conclusions? | (9) Methods used to synthesize the findings of studies appropriate? | (10) Likelihood of publication bias assessed? | (11) Conflict of interest stated?
| Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Roelofs, 2008 | Yes |
| Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes |
| Good |
Please see Appendix C. Included Studies for full study references.
Table F4Quality assessment of randomized controlled trials of NSAIDs
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Herrmann, 2009 | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Fair |
Majchrzycki, 2014 | Yes | No | Yes | No | No | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | No | Yes | Fair |
Shirado, 2010 | Yes | No | Yes | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F5Quality assessment of systematic reviews of opioids
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carson, 2011 | Yes |
| Yes | No | No | Yes | No- only 4 of 38 excluded full text articles were listed in Appendix D | Yes |
| Qualitatively, yes | Yes |
| Unclear | Good |
Chaparro, 2013 | Yes | Yes to both | Yes | Yes | No | Yes | Yes- but only for 36 of 76 excluded articles | Yes | Yes to both | No, except for analysis 4.1, examining results of studies with “enhanced enrollment”, meaning patients were enrolled only if they benefitted from opioids and tolerated side effects, then were randomized to opioid withdrawal. | Yes |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F6Quality assessment of randomized controlled trials of opioids
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in All Groups Similar | Intention-to-Treat Analysis | Is There A Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cloutier, 2013 | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Yes | No; <20% | Yes | Yes | Unclear | Unclear | Good |
Hyup Lee, 2013 | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | No; 21% | Yes | Yes | Yes | Yes | Good |
Rauck, 2014 | Unclear | Unclear | No; not sex | Yes | Yes | Unclear | Yes | Yes | Yes | No; 39% | Yes | Yes | No | Yes | Poor |
Schiphorst Preuper, 2014 | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Fair |
Please see Appendix C. Included Studies for full study references.
Table F7Quality assessment of randomized controlled trials of SMRs
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment In All Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pareek, 2009 | Unclear | Unclear | Yes | Yes | Unclear | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Ralph, 2008 | Unclear | Unclear | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F8Quality assessment of randomized controlled trials of benzodiazepines
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brotz, 2010 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F9Quality assessment of systematic reviews of antidepressants
Study, Year | (1) ‘A priori’ design provided? | (2) Duplicate study selection and data extraction?
| (3) Comprehensive literature search performed? | (4) Status of publication used as an inclusion criteria? | (5) List of studies (included and excluded) provided? | (6) Characteristics of the included studies provided? | (7) Scientific quality of included studies assessed and documented? | (8) Scientific quality of the included studies used appropriately in formulating conclusions? | (9) Methods used to synthesize the findings of studies appropriate? | (10) Likelihood of publication bias assessed? | (11) Conflict of interest stated?
| Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Urquhart, 2010 | Yes |
| Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes |
| Good |
Please see Appendix C. Included Studies for full study references.
Table F10Quality assessment of randomized controlled trials of antidepressants
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Farajirad, 2013 | Unclear | Unclear | Yes | Unclear | No | No | Unclear | Unclear | No | Unclear | Unclear | Unclear | Unclear | Unclear | Poor |
Mazza, 2010 | Unclear | Unclear | Yes | Unclear | Unclear | Unclear | Yes | Unclear | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Skljarevski, 2009 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Unclear | Unclear | Good |
Skljarevski, 2010 (Journal of Pain) | Unclear | Unclear | Unclear | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | No | Unclear | Unclear | Fair |
Skljarevski, 2010 (Spine) | Unclear | Unclear | Unclear | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | No | Unclear | Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F11Quality assessment of randomized controlled trials of antiseizure medications
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baron, 2010 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Fair |
Baron, 2014 | Unclear | Unclear | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Fair |
Kalita, 2014 | Yes | Unclear | Yes | No | No | No | Yes | Unclear | Yes | No | Yes | Yes | Yes | Yes | Poor |
Markman, 2014 | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Fair |
Pota, 2012 | Unclear | No | Yes | Yes | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | No | Yes | Fair |
Romano, 2009 | Unclear | Unclear | Unclear | Yes | Yes | Unclear | Yes | Unclear | Yes | Yes | Yes | No | Unclear | Yes | Fair |
Yaksi, 2007 | Unclear | Unclear | Yes | Unclear | Unclear | Unclear | Yes | Unclear | No | Unclear | Yes | Unclear | Unclear | Yes | Poor |
Please see Appendix C. Included Studies for full study references.
Table F12Quality assessment of randomized controlled trials of corticosteroids
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eskin, 2014 | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Unclear | Yes | Fair |
Friedman, 2008 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Good |
Hedeboe, 1982 | Unclear | Unclear | Unclear | Yes | Yes | Unclear | Yes | Unclear | No | Unclear | Yes | Yes | Unclear | Unclear | Fair |
Holve, 2008 | No (sequential allocation) | No | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Poor |
Rodrigues, 2014 | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Fair |
Please see Appendix C. Included Studies for full study references.
Table F13Quality assessment of systematic reviews of exercise
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bystrom, 2013 | Yes | a. Yes; b. no | >2 databases through October 2011; no mention of “plus” sources | No | Not stated | Yes | No | Yes |
| No; no information on heterogeneity provided | Yes |
| Unclear | Fair |
Oesch, 2010 | Yes | a. Yes; b. No | Yes, >2 databases through Aug 2008; checked refs | No | Not stated | Yes | No | Yes |
| Metaregresion-NS Effect of specific exercise characteristics; sensitivity by study quality; funnel plot | Yes |
| Yes | Fair |
van Middelkoop, 2010 | Yes | a. Yes; b. Yes | Data bases through 2008 for CLBP only; unclear if additional sources | Cite Cochrane Back group strategy used - assume no restriction? | Cite Cochrane Back group strategy used - assume so? | Not explicitly; references provided | No | No |
| No | Yes |
| Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F14Quality assessment of randomized controlled trials of exercise
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in All Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Albaladejo, 2010 | Yes | Yes | Yes | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Fair (but results reporting poor) |
Albert, 2012 | Yes | No | Yes | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Fair |
Bronfort, 2011 | Yes | Yes | Yes | No | No | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Good |
Garcia, 2013 | Yes | Yes | Yes | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Good |
George, 2008 | Yes | No | No | No | No | Yes | Unclear | Unclear | Yes | No | Yes | Yes | Yes | Unclear | Poor |
Hagen, 2010 | Yes | No | Yes | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | No | Unclear | Fair |
Hartvigsen, 2010 | Unclear | Yes | Yes | No | No | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Fair |
Helmhout, 2008 | Yes | Unclear | No | No | No | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Poor |
Henchoz, 2010 | Unclear | Unclear | Yes | No | No | No | Unclear | No | Yes | Yes | Yes | Yes | No | Yes | Poor |
Hofstee, 2002 | Yes | No | No | No | No | No | No | Unclear | Yes | Yes | Yes | Yes | No | Unclear | Poor |
Hurley, 2015 | Yes | Yes | Yes | No | No | Yes | Unclear | No | Yes | No | Yes | Yes | Yes | Yes | Fair |
Jensen, 2012 | Yes | Yes | Yes | No | No | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Good |
Kell, 2011 | Unclear | Unclear | Yes | No | No | Unclear | Unclear | Unclear | No | Unclear | Yes | Unclear | No | Yes | Poor |
Little, 2008 | Yes | Yes | Yes | No | No | Yes | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Good |
Macedo, 2012 | Yes | Yes | Yes | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear/fair |
Machado, 2010 | Yes | Yes | Yes | No | No | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Fair |
Pengel, 2007 | Yes | Yes | Yes | Unclear/ sham | No | Yes | No | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F15Quality assessment of systematic reviews of Pilates
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wells, 2014 | Yes | a. Yes; b. No | Yes, >2 databases including CINAHL, Cochrane Library, Scopus | No | Yes (Proquest - dissertations and theses; Nursing and Allied Health Source; hand search of bibliographies | Yes | No | Yes | Yes: Modified Guidelines for use of the McMasters Critical Appraisal Form for Quantitative Studies | No; no metaanalysis done; quality rating | No ; Study quality (high vs. low quality) described w/results; conclusions regarding pain short term - may be over stated; |
| Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F16Quality assessment of randomized controlled trials of tai chi
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in All Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hall, 2011 | Yes | Yes | Yes | No | No | No | Unclear | Yes | Yes | Yes | Yes | Yes | No | Yes | Fair |
Weifen, 2013 | Unclear | Unclear | Yes | No | No | Yes | Unclear | Yes | No | Unclear | Yes | Unclear | No | Yes | Fair |
Please see Appendix C. Included Studies for full study references.
Table F17Quality assessment of systematic reviews of yoga
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cramer, 2013 | Yes |
| January 2012: Medline, EMBASE, the Cochrane Library, PsycINFO, and CAMBASE | Yes | No | Yes | Yes - full text; reason with citation | Yes |
| Yes; high vs. low ROB; if heterogeneity | Study quality considered; Conclusions regarding pain, disability are supported; HRQOL conclusions - seem to be downgraded more (short term) than rating scheme might suggest? Limited info on adverse events available, but conclude that Yoga not associated with serious adverse events |
| Unclear | Good |
Please see Appendix C. Included Studies for full study references.
Table F18Quality assessment of randomized controlled trials of yoga
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in All Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nambi, 2014 | Yes | Unclear | Yes | No | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | No | unclear | Poor |
Saper, 2013 | Yes | Unclear | No (But adjusted estimates for baseline differences were essentially the same as crude estimates) | No | Unclear | Yes | Yes use of other treatments overall: 53% (26/47) vs.. 61% (28/44); similar % for massage, PH, acupuncture, chiropractic, epidural injections | No; attendance: 65% for once weekly class, 44% for twice weekly classes | Yes | Yes | Yes | Yes | Yes | Yes | Fair |
Please see Appendix C. Included Studies for full study references.
Table F19Quality assessment of systematic reviews of psychological therapies
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Henschke, 2010 | Yes |
| Yes | Yes | Unclear | Yes | Yes | Yes |
| No | Yes (yes) |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F20Quality assessment of randomized controlled trials of psychological therapy
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in All Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kahn, 2014 | Yes | Unclear | Unclear (age, sex, duration of pain NR, slight differences in pain and function at baseline) | Yes (statement that patients were blind to the study) | No (but blinding not possible for these interventions) | Yes (outcomes patient reported) | Unclear | Unclear | Yes | Yes (100%) | Yes | Unclear | No | Yes | Fair |
Lamb 2010/2012 | Yes | Yes | Yes | No | No (but blinding not possible for these interventions) | Yes | No (control group free to seek any additional care on their own; additional treatments received not reported) | No Intervention group: 63% (294/468) Control group: 100% (233/233) | Yes | Yes (85% in both groups) | Yes | No | Yes | Yes | Fair |
Siemonsma, 2013 | Yes | Yes | Yes | No | No (but blinding not possible for these interventions) | Yes | Yes | No Intervention group: 81.7% Control group (waiting list, no interventions permitted): Unclear | Yes | Yes (89% was lowest f/u reported (for activity-specific pain, 139/156) | Yes | No (Their fig 1 makes it look like all pts randomized were included in the primary analysis but the paragraph under “Primary Outcome” contradicts this.) | Yes | Yes | Fair |
Vong, 2011 | Yes | Unclear | Yes | Yes (patients told they would receive one of two types of conventional patient treatment but did not know anything about motivational enhancement therapy) | No (but blinding not possible for these interventions) | Yes (outcomes patient reported) | Yes | No Intervention group: 62% Control group: 63% (% of patients who participated fully) | Yes | yes (86%) | Yes | No (they said they used ITT but 12 patients who were randomized did not receive treatment and were excluded from all analyses) | No | Yes | Fair |
Table F21Quality assessment of systematic reviews of multidisciplinary rehabilitation
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kamper, 2014 | Yes |
| Yes | Yes | No | Yes | No | Yes |
| Yes | Yes |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F22Quality assessment of randomized controlled trials of multidisciplinary rehabilitation
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in All Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eisenberg, 2012 | Yes | Unclear | Yes | No | No | Unclear | NA | Yes | Yes | Yes | Yes | Yes | No | Unclear | Good |
Gatchel, 2003 | Yes | Unclear | Unclear | No | No | Unclear | NA | Yes | No | NA | Yes | Unclear | Yes | Unclear | Fair |
Monticone, 2014 | Yes | Unclear | Yes | Yes | No | Unclear | NA | Yes | Yes | Yes | Yes | Yes | No | Unclear | Good |
Please see Appendix C. Included Studies for full study references.
Table F23Quality assessment of systematic reviews of acupuncture
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lam, 2013 | Unclear |
| Yes | Yes | No | Yes | No | Yes |
| No | Unclear |
| No | Fair |
Lee, 2013 | Unclear |
| Yes | Yes | Yes | Yes | No | Yes |
| Yes | Yes |
| No | Fair |
Please see Appendix C. Included Studies for full study references.
Table F24Quality assessment of randomized controlled trials of acupuncture
Author, Year | Randomization adequate? | Allocation concealment adequate? | Groups similar at baseline? | Eligibility criteria specified? | Patients masked? | Care provider masked? | Outcomes assessors masked? | Attrition and withdrawals reported? | Attrition acceptable and comparable? | Analyze people in the groups in which they were randomized | Primary outcome specified and reported? | Other issues | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cho, 2013 | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Hasagawa, 2014 | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Vas, 2012 | Yes | Yes | Yes | Yes | Yes (for acupuncture and sham groups only) | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Yun, 2012 (back points) | Yes | Unclear, but likely ok - just says “central randomization with random block sizes” | Yes | Yes | Yes (only for acupuncture groups, not for usual care group) | No | Yes | Yes | Yes | Yes | Yes | None | Fair |
Weiss, 2013 | Unclear | Unclear | Yes | Yes | Unclear | Unclear | Unclear | Yes | Yes | Yes | Unclear | Exploratory only | Poor |
Please see Appendix C. Included Studies for full study references.
Table F25Quality assessment of systematic reviews of massage
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Furlan, 2010 | Yes |
| Yes | Yes | Yes | Yes | Yes | Yes |
| Yes | Yes |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F26Quality assessment of randomized controlled trials of massage
Author, Year | Randomization adequate? | Allocation concealment adequate? | Groups similar at baseline? | Eligibility criteria specified? | Outcome assessors masked? | Care provider masked? | Patient masked? | Attrition and withdrawals reported? | Attrition acceptable and comparable? | Analyze people in the groups in which they were randomized | Primary outcome specified and reported? | Other issues? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajimsha, 2014 | Unclear | No | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | None | Fair |
Borges, 2014 | Yes | Unclear | Yes | Yes | Unclear | No | Unclear | Yes | Yes | Yes | Yes | None | Fair |
Cherkin, 2011 | Yes | Yes | Yes | Yes | Yes - for the two massage groups only | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Kong, 2012 | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Romanowski, 2012 | Unclear | Unclear | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | None | Poor |
Sritooma, 2014 | Yes | Unclear | Yes | Yes | No | No | No - not described | Yes | Yes | Yes | Yes | None | Fair |
Zhang, 2015 | No | No | Yes | Yes | Yes | No | Unclear | Yes | Yes | Yes | Yes | None | Fair |
Zheng, 2012 | Yes | Unknown | Yes | Yes | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | None | Fair |
Please see Appendix C. Included Studies for full study references.
Table F27Quality assessment of systematic reviews of spinal manipulation
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rubinstein, 2011 | Yes |
| Yes | Yes | Yes | Yes | Yes | Yes |
| Yes | Yes |
| Yes | Good |
Rubinstein, 2012 | Yes |
| Yes | Unclear | Yes, but excluded from analysis | Yes | Yes | Yes |
| Yes | Yes |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F28Quality assessment of randomized controlled trials of SMT
Author, Year | Randomization adequate? | Allocation concealment adequate? | Groups similar at baseline? | Eligibility criteria specified? | Patient masked? | Care provider masked? | Outcomes assessor masked? | Attrition and withdrawals reported? | Attrition acceptable and comparable? | Analyze people in the groups in which they were randomized | Primary outcome specified and reported? | Other issues | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balthazard, 2012 | Yes | Unclear | Yes - although pain slightly higher in sham group (53 vs. 62) but not statistically significant | Yes | No | No | Unclear | Yes | Yes | Yes | Yes | None | Fair |
Bicahlo, 2010 | Yes | Unclear | Yes | Yes | No | No | Unclear | Yes | Yes | Yes | Yes | Incomplete reporting of outcomes (function) | Fair |
Bronfort, 2004 | Yes | No | Yes | Yes | No | No | No | No | Unclear | Yes | No | Primary outcome not specified | Poor |
Bronfort, 2011 | Yes | Yes | Yes | No | No | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Good |
Bronfort, 2014 | Yes - minimization used, not randomization | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | None | Fair - not blinded |
Burton, 2000 | Yes | Yes | Yes | Yes | No | No | No | Yes | Unclear | Yes | Yes | None | Poor |
Cecchi, 2010 | Yes | Unclear | No - sick leave higher in back school group compared to other groups | Yes | No | No | Unclear | Yes | Yes | Yes | Yes | None | Fair |
De Oliviera, 2013 | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Goertz, 2013 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | No - low followup rate in the SMC group | Yes | Yes | None | Fair |
Haas, 2014 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Paatelma, 2008 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | No - high drop out rate | Yes | Yes | None | Fair |
Petersen, 2011 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Santilli, 2006 | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | None | Good |
Schneider, 2015 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | None | Good |
Senna, 2011 | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | No - low followup rate in sham SMT group | Yes | Yes | None | Fair |
Von Heymann, 2013 | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | No - low followup rate | Yes | Yes | Unclear intervention (Single treatment?), small sample size with high drop out rate | Fair |
Please see Appendix C. Included Studies for full study references.
Table F29Quality assessment of systematic reviews of ultrasound
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ebadi, 2014 | Yes | Yes/Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes (considered in SOE analyses) | Yes | Yes/No | Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F30Quality assessment of randomized controlled trials of ultrasound
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality (Cochrane Back Group) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bronfort, 2011 | Yes | Yes | Yes | No | No | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Good |
Fiore, 2011 | Yes | Yes | Unclear | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Goren, 2010 | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Licciardone, 2013 | Yes | Yes | Yes | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Good |
Unlu, 2008 | Unclear | Unclear | Yes | No | No | Unclear | Unclear | Unclear | No | Unclear | Yes | Unclear | Unclear | Unclear | Poor |
Please see Appendix C. Included Studies for full study references.
Table F31Quality assessment of systematic reviews of TENS
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
van Middelkoop, 2011 | Yes |
| Yes | Yes | Unclear | Yes | No | Yes |
| Unclear | Yes |
| Unclear | Good |
Please see Appendix C. Included Studies for full study references.
Table F32Quality assessment of randomized controlled trials of TENS
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buchmuller, 2012 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | No | Yes | Unclear | Unclear | Unclear | Fair |
Facci, 2011 | Yes | Yes | No; significant difference between TENS and control in pain intensity at baseline (p=0.009) | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Good |
Shimoji, 2007 | Unclear | Unclear | Yes | Yes | Unclear | Yes | Yes | Yes | No | Unclear | Yes | Unclear | Unclear | Unclear | Fair |
Tsukayama, 2002 | Yes | Unclear | Yes | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F33Quality assessment of randomized controlled trials of electrical stimulation
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality (Cochrane Back Group) | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Durmus, 2009 | Unclear | Unclear | Yes | No | No | Unclear | Unclear | Unclear | No | Unclear | Yes | Unclear | Unclear | Yes | Poor | Some outcomes assessed as means and others as medians, no explanation provided |
Durmus, 2010 | Unclear | Unclear | Yes | No | No | Unclear | Unclear | Unclear | Yes | Yes | Yes | No | Unclear | Yes | Poor | Some outcomes assessed as means and others as medians, no explanation provided |
Glaser, 2001 | Yes | Unclear | Yes | Yes | Yes | Unclear | Unclear | Unclear | Yes | No | Yes | No | Unclear | Yes | Poor | Very high loss to followup |
Moore, 1997 | Unclear | Unclear | Unclear | Yes | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Yes | No | Unclear | Yes | Poor | Crossover design, results of first intervention not reported and carryover effects not assessed |
Pope, 1994 | Yes | Unclear | Unclear | No | No | Yes | Unclear | No | Yes | Yes | Yes | Unclear | Yes | Yes | Fair |
Please see Appendix C. Included Studies for full study references.
Table F34Quality assessment of randomized controlled trials of PENS
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hamza, 1999 | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Yes | No | Yes | Unclear | Unclear | Unclear | Poor |
Pérez-Palomares, 2010 | Yes | Unclear | Unclear | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Unclear | Unclear | Unclear | Poor |
Weiner, 2008 | Yes | Unclear | Yes | Yes | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Fair |
Please see Appendix C. Included Studies for full study references.
Table F35Quality assessment of randomized controlled trials of interferential therapy
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lara-Palomo, 2013 | Yes | Yes | Yes | No | No | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Fair |
Please see Appendix C. Included Studies for full study references.
Table F36Quality assessment of systematic reviews of heat-cold
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
French, 2006 Updated in French, 2011 | Yes |
| Yes | Unclear | Unclear | Yes | Yes (no reasons for exclusion provided) | Yes |
| No | Yes |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F37Quality assessment of randomized controlled trials of heat-cold
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dehgan, 2014 | Unclear | Unclear | Unclear | No | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Kettenmann, 2007 | Unclear | Unclear | Yes | No | Unclear | Unclear | Yes | Unclear | Yes | No | Yes | No | Unclear | Unclear | Fair |
Stark, 2014 | Unclear | Unclear | Yes | No | Unclear | Unclear | Yes | Unclear | No | Unclear | Yes | Yes | Yes | Unclear | Fair |
Tao, 2005 | Unclear | Unclear | Yes | No | Unclear | Unclear | Unclear | Unclear | No | Unclear | Yes | Unclear | Unclear | Unclear | Poor |
Please see Appendix C. Included Studies for full study references.
Table F38Quality assessment of randomized controlled trials of LLLT
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ay, 2010 | Yes | Unclear | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Good |
Djavid, 2007 | Unclear | Yes | Yes | Unclear | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | No | Unclear | Unclear | Fair |
Hsieh, 2014 | Yes | Yes | Yes | Yes | No | Unclear | Unclear | Unclear | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Jovicic, 2012 | Unclear | Unclear | Yes | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Konstantinovic, 2010 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Good |
Vallone, 2014 | Yes | Yes | Unclear | Yes | Unclear | Unclear | Yes | Unclear | No | Unclear | Yes | Unclear | Unclear | Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F39Quality assessment of randomized controlled trials of diathermy
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ahmed, 2009 | Unclear | Unclear | Unclear | Yes | Unclear | Unclear | Unclear | Unclear | No | Unclear | Yes | No | Unclear | Unclear | Poor |
Shakoor, 2008 | Unclear | Unclear | Unclear | Yes | Unclear | Unclear | Yes | Unclear | No | Unclear | Yes | No | Unclear | Unclear | Poor |
Please see Appendix C. Included Studies for full study references.
Table F40Quality assessment of systematic reviews of lumbar supports
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
van Duijvenbode, 2011 | Yes |
| Yes | Yes | Unclear | Yes | Yes | Yes |
| Yes | Yes |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F41Quality assessment of randomized controlled trials of lumbar support
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in all Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment In All Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calmels, 2009 | Yes | Unclear | Yes (reported in text; data not shown for some characteristics) | No | No | Unclear | Yes | Unclear | Yes | Yes | Yes | No | Unclear | Unclear | Fair |
Morrisette, 2014 | Yes | Yes | Yes | No | No | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Oleske, 2007 | Yes | Yes | Yes | No | No | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Sato, 2012 | Yes | Unclear | Yes (reported in text; data not shown) | No | No | Unclear | Yes | Unclear | Yes | Yes | Yes | No | Unclear | Unclear | Fair |
Please see Appendix C. Included Studies for full study references.
Table F42Quality assessment of systematic reviews of traction
Author, Year | “A priori” design provided? | Duplicate study selection and data abstraction?
| Comprehensive literature search performed? | Non-English language studies considered for inclusion? | Conducted searches for unpublished (gray) literature? | List of included studies provided? | List of excluded studies provided with reasons? | Characteristics of the included studies provided? | Scientific quality of included studies:
| Sensitivity analyses or stratified analyses conducted according to study quality? | Study conclusions supported by the evidence? (Was study quality considered in the synthesis?) | Conflict of interest stated?
| Multidisciplinary systematic review team? | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wegner, 2013 | Yes |
| Yes | Yes | Yes | Yes | Yes | Yes |
| Yes | Yes |
| Yes | Good |
Please see Appendix C. Included Studies for full study references.
Table F43Quality assessment of randomized controlled trials of traction
Author, year | Randomization | Concealed treatment allocation | Baseline group similarity | Patient blinded | Care provider blinded | Outcome assessor / Data analyst blinded | Cointerventions avoided or similar | Compliance acceptable in all groups | Attrition reported | Attrition acceptable | Timing of outcome assessment in all groups similia | Intention-to-treat analysis | Is there a registered or published protocol | Avoidance of selective outcomes reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diab, 2012 and Diab, 2013 | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | Fair |
Moustafa, 2013 | Yes | Yes | Yes | No | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Fair |
Prasad, 2013 | Unclear | Unclear | Yes | No | Yes | Unclear | Yes | Unclear | Yes | No | Yes | No | Unclear | Unclear | Poor |
Please see Appendix C. Included Studies for full study references.
Table F44Quality assessment of randomized controlled trials of taping
Author, Year | Randomization | Concealed Treatment Allocation | Baseline Group Similarity | Patient Blinded | Care Provider Blinded | Outcome Assessor / Data Analyst Blinded | Cointerventions Avoided or Similar | Compliance Acceptable in All Groups | Attrition Reported | Attrition Acceptable | Timing of Outcome Assessment in all Groups Similar | Intention-to-Treat Analysis | Is There a Registered or Published Protocol | Avoidance of Selective Outcomes Reporting | Quality Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bae, 2013 | Unclear | Unclear | Yes | No | No | Unclear | Yes | Unclear | No | Unclear | Yes | Yes | Unclear | Yes | Fair |
Castro-Sanchez, 2012 | Yes | Yes | P | Yes | No | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Good |
Chen, 2012 | Unclear | Unclear | Yes | No | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Fair |
Kachanathu, 2014 | Unclear | Unclear | Unclear | No | No | Unclear | Unclear | Unclear | No | Unclear | Yes | Unclear | Unclear | Yes | Poor |
Paolini, 2011 | Yes | Unclear | Yes | No | No | Unclear | Unclear | Unclear | No | Unclear | Yes | Unclear | Unclear | Yes | Fair |
Silva Parreira, 2014 | Yes | Yes | Yes | Yes | No | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Good |
Please see Appendix C. Included Studies for full study references